Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NewAmsterdam Pharma (NAMS) Return on Capital Employed (2024 - 2025)

NewAmsterdam Pharma's Return on Capital Employed history spans 2 years, with the latest figure at 0.08% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 25.0% year-over-year to 0.08%; the TTM value through Dec 2025 reached 0.08%, up 25.0%, while the annual FY2025 figure was 0.07%, 28.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.08% at NewAmsterdam Pharma, up from 0.27% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.08% in Q4 2025 and bottomed at 0.55% in Q1 2024.